Literature DB >> 29846206

Sepsis-induced myocardial dysfunction.

Keith R Walley1.   

Abstract

PURPOSE OF REVIEW: Sepsis leads to a complex intramyocardial inflammatory response that results in sepsis-induced myocardial dysfunction. Here, recent findings are reviewed in a physiologic context. RECENT
FINDINGS: Decreased systolic contractility during sepsis limits ventricular ejection and stroke volume. Initially, this effect is compensated for by increased diastolic filling during volume resuscitation. Reduced afterload due to arterial vasodilation also compensates so that cardiac output can be maintained or increased. Recent results recognize the importance of diastolic dysfunction, reduced ventricular diastolic compliance that impedes ventricular filling. Diastolic dysfunction becomes increasingly important as severity of septic shock increases. When impaired ventricular ejection is coupled with limited diastolic filling, stroke volume must decrease. Accordingly, diastolic dysfunction is more closely related to mortality than systolic dysfunction. Recent trials of beta-adrenergic agonists and levosimendan have been disappointing, while approaches to modulating the intramyocardial inflammatory response show promise.
SUMMARY: Sepsis-induced myocardial dysfunction is increasingly recognized as a major contributor to outcome of septic shock. Significant strides have been made in understanding the intramyocardial inflammatory response that causes myocardial dysfunction. A number of novel approaches show promise by modulating the intramyocardial inflammatory response.

Entities:  

Mesh:

Year:  2018        PMID: 29846206     DOI: 10.1097/MCC.0000000000000507

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  31 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

2.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

Review 3.  Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy.

Authors:  Oluwabukunmi Modupe Salami; Olive Habimana; Jin-Fu Peng; Guang-Hui Yi
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-15       Impact factor: 3.727

4.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

5.  LncRNA MALAT1 Regulates USP22 Expression Through EZH2-Mediated H3K27me3 Modification to Accentuate Sepsis-Induced Myocardial Dysfunction.

Authors:  Hong Xu; Wei Ye; Baochang Shi
Journal:  Cardiovasc Toxicol       Date:  2022-06-20       Impact factor: 2.755

6.  Risk factors for postoperative sepsis-induced cardiomyopathy in patients undergoing general thoracic surgery: a single center experience.

Authors:  Yinghua Wang; Xinming Zhai; Minfang Zhu; Yan Pan; Min Yang; Kaiyan Yu; Ben He
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

7.  Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production.

Authors:  Xin-Tong Wang; Zhen Peng; Ying-Ying An; Ting Shang; Guangxu Xiao; Shuang He; Xi Chen; Han Zhang; Yuefei Wang; Tao Wang; Jun-Hua Zhang; Xiumei Gao; Yan Zhu; Yuxin Feng
Journal:  Front Pharmacol       Date:  2021-04-13       Impact factor: 5.810

8.  Exploring the beneficial role of telmisartan in sepsis-induced myocardial injury through inhibition of high-mobility group box 1 and glycogen synthase kinase-3β/nuclear factor-κB pathway.

Authors:  Yan Jin; Hong Wang; Jing Li; Minyan Dang; Wenzhi Zhang; Yan Lei; Hao Zhao
Journal:  Korean J Physiol Pharmacol       Date:  2020-07-01       Impact factor: 2.016

9.  MG53 Protects against Sepsis-Induced Myocardial Dysfunction by Upregulating Peroxisome Proliferator-Activated Receptor-α.

Authors:  Xue Han; Daili Chen; Ning Liufu; Fengtao Ji; Qingshi Zeng; Weifeng Yao; Minghui Cao
Journal:  Oxid Med Cell Longev       Date:  2020-08-27       Impact factor: 6.543

10.  Oxygen Delivery and Oxygen Consumption in Pediatric Fluid Refractory Septic Shock During the First 42 h of Therapy and Their Relationship to 28-Day Outcome.

Authors:  Chulananda D A Goonasekera; Joseph A Carcillo; Akash Deep
Journal:  Front Pediatr       Date:  2018-10-23       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.